Sign in

CIK 0001158780 · Non-accelerated filer<br>Smaller reporting company

Ticker
PLUR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Jun 30
Incorporated
NV
Entity type
operating
EIN
980351734
Phone
972-74-710-7171
Business address
MATAM ADVANCED TECHNOLOGY PARK, BUILDING NO. 5, HAIFA, Israel
Former names
PLURISTEM THERAPEUTICS INC, PLURISTEM LIFE SYSTEMS INC, AI SOFTWARE INC
Open-market buys, last 90 days
$1,250,001
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$1,250,001. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Manieu Alexandre Weinstein +$1.3M Director 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-09-18 Franco-Yehuda Chen Chief Financial Officer Grant or award +8,413 67,503
2024-01-23 Franco-Yehuda Chen Chief Financial Officer Grant or award +355,000 472,716
2024-01-23 Aberman Zami Director Grant or award +44,100 1,536,073
2024-01-23 Shemesh-Rasmussen Maital Director Grant or award +38,150 58,150
2024-01-23 Birger Pinhas Doron Director Grant or award +39,900 59,900
2024-01-23 Abony Lorne Kenneth Director Grant or award +36,750 36,750
2024-01-23 YANAY YAKY Chief Executive Officer Grant or award +700,000 2,460,125
2024-01-23 Levi Rami Avraham Director Grant or award +37,100 57,100
2023-07-11 Abony Lorne Kenneth Director Grant or award · Stock Option (Right to Buy) +100,000 100,000
2022-12-22 YANAY YAKY Chief Executive Officer Grant or award +334,821 1,760,125
2022-12-22 YANAY YAKY Chief Executive Officer Grant or award · Share Option (right to buy) +334,821 334,821
2022-12-22 YANAY YAKY Chief Executive Officer Grant or award · Share Option (right to buy) +500,000 500,000
2022-12-22 YANAY YAKY Chief Executive Officer Grant or award · Share Option (right to buy) +500,000 500,000
2022-12-22 YANAY YAKY Chief Executive Officer Grant or award · Share Option (right to buy) +500,000 500,000
2022-12-20 Aberman Zami Director Sale −2,000 $0.97 $2K 1,491,973
2022-02-10 Aberman Zami Director Purchase +80,616 $1.80 $145K 91,756
2021-07-15 Shalev Varda Director Grant or award +20,000 20,000
2021-07-15 Birger Pinhas Doron Director Grant or award +20,000 20,000
2021-05-28 CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP 10% owner Sale −70,007 $3.72 $260K 3,166,918
2021-05-28 CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP 10% owner Sale −45,000 $3.72 $167K 3,121,918

Page 3 of 9 · 165 trades